Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 4: Apolipoproteinopathia.

Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 4: Apolipoproteinopathia. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 4: Apolipoproteinopathia. Abstract Text:

B Choluj,T Votruba,

The article defines apolipoprotein diseases as the structural defects of apolipoproteins or disorders in their synthesis or secretion. The survey covers a range of atherogenous defects, providing a detailed description of their clinical-biochemical and genetic aspects as well as diagnostic and differential diagnostic criteria. Attention is paid also to the significance of analytical isoelectric focusing.

Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 4: Apolipoproteinopathia. Publishing Authors By Initials

B Choluj,T Votruba,

For similar male research abstracts see: male research

PUBMED ID PMID:

MEDLINE DATE:

Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 4: Apolipoproteinopathia. Journal Published:

PUBLICATION TYPE: Review

Journal: Acta Universitatis Carolinae. Medica

VOLUME: 37

Page Numbers: 129-40

Journal Abbreviation:

ISSN: 0001-7116

DAY: 20

MONTH: 02

YEAR: 1991

Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 4: Apolipoproteinopathia. Information

Number of References: 36

LANGUAGE: eng

NlmUniqueID: 2985169

Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 4: Apolipoproteinopathia. Keywords Mesh Terms:

KEYWORDS: Male

MESH TERMS: complications

Chemical & Substance for Abstract: Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 4: Apolipoproteinopathia. Information

Substance Name: Apolipoproteins

Registry Number: 0

Grant and Affiliation Information for Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 4: Apolipoproteinopathia.

AFFILIATION: Department of Clinical Biochemistry, Central Military Hospital, Prague, Czechoslovakia.

Country: CZECHOSLOVAKIA

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Acta Univ Carol [Med] (Praha)

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis Part 4: Apolipoproteinopathia Related Publications

• A missense mutation in the murine Opa3 gene models human Costeff syndrome.
• An "overtrained" ophthalmologist responds.
• Experience with evaluation of knowledge in technical disciplines.
• Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 2: Hypercholesterolemia.
• Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 3: Hypertriacylglycerolemia.
• Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 4: Apolipoproteinopathia.
• Medical cost savings associated with 17 alpha-hydroxyprogesterone caproate.
• Pyrimidine acyclic nucleoside phosphonates and phosphorylated analogs (part 2): syntheses and investigation of their inhibitory effects towards human thymidine phosphorylase.
• Systems analysis of the culture physiology in acetone-butanol fermentation.
• Thymoxamine in the treatment of traumatic mydriasis.